Cardiovascular Diagnostic Testing Market to Reach $15.43 Bn, Globally, by 2030 at 8.3% CAGR: Allied Market Research

News provided by

Dec 15, 2021, 22:35 ET

PORTLAND, Ore., Dec. 16, 2021 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Cardiovascular Diagnostic Testing Market by Type (Laboratory Developed Tests and In-Vitro Diagnostic Tests), Panel (Atherosclerotic Cardiovascular Disease Risk Panel with Score), and End User (Laboratory Testing Facilities, Academic Institutes, and Point-of-Care Testing Facilities): Global Opportunity Analysis and Industry Forecast, 2021-2030". As per the report, the global cardiovascular diagnostic testing industry generated $6.87 billion in 2020, and is estimated to reach $15.43 billion by 2030, growing at a CAGR of 8.3% from 2021 to 2030.

Download Sample Report- https://www.alliedmarketresearch.com/request-sample/14656

Major determinants of the market growth

Rise in medical technology innovations, initiatives to spread awareness among patients, and surge in geriatric population along with rise in prevalence of cardiovascular diseases have boosted the growth of the global cardiovascular diagnostic testing market. However, changes in FDA regulation and guidance of LDTs and limited insurance coverage and high cost of devices hinder the market growth. On the contrary, development of healthcare infrastructure in emerging nations is expected to open new opportunities for the market players in the future.

Covid-19 scenario:

The Covid-19 pandemic has a positive impact on the market as the Covid-19 infection has severe imprecations in the cardiovascular system.
The Covid-19 pandemic can promote several cardiovascular disorders such as arrhythmias, myocardial injury, and acute coronary syndrome.
The Covid-19 pandemic has highlighted the importance of reliable diagnostic tests and the quick development of novel assays.

Get detailed COVID-19 impact analysis on the Cardiovascular Diagnostic Testing Market- https://www.alliedmarketresearch.com/request-for-customization/14656?reqfor=covid

The in-vitro diagnostic test segment dominated the market

By type, the in-vitro diagnostic segment held the largest share in 2020, accounting for more than 90% of the global cardiovascular diagnostic testing market, due to increase in demand for non-invasive diagnostic techniques and technological advancements that allow replacing old conventional devices with new ones. However, the laboratory-developed test segment is projected to manifest the highest CAGR of 11.2% during the forecast period, as they offer accurate, quality testing for several cardiovascular diseases.

The point of care testing facilities segment to portray the highest CAGR through 2030

By end user, the point of care testing facilities segment is expected to portray the highest CAGR of 8.7% during the forecast period, as it enables rapid detection of analytes near to the patient, which facilitates quick medical decisions and better disease diagnosis, management, and monitoring. However, the laboratory testing facilities segment held the largest share in 2020, contributing to more than two-fifths of the global cardiovascular diagnostic testing market, owing to rise in prevalence of cardiovascular diseases and increase in demand for laboratory testing.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/14656

North America held the lion's share

By region, the global cardiovascular diagnostic testing market across North America dominated the market in 2020, accounting for more than two-fifths of the market, due to high prevalence of cardiovascular diseases, rise in awareness about various heart diseases, and presence of large number of domestic manufactures of in-vitro diagnostic machines. However, the market across Asia-Pacific is anticipated to register the highest CAGR of 9.4% during the forecast period, owing to high per capita income, improvement in healthcare infrastructure, and rise in disposable income.

Major market players

Abbott Laboratories
bioMérieux, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd
Danaher Corporation
PerkinElmer, Inc.
Thermo Fisher Scientific, Inc.
Siemens AG
Tosoh Corporation

Official Press Release: https://www.alliedmarketresearch.com/press-release/cardiovascular-diagnostic-testing-market.html

Similar Research Reports for Information, Communication and Technology:

Paclitaxel-eluting Stent Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Hysteroscope Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Interventional Oncology Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Intraosseous Infusion Device Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Orthopedic Consumables Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter